Lovesac Maintains FY26 Outlook

Lovesac Co. (LOVE) reported Q1 results and issued weaker-than-expected guidance for Q2, projecting a loss of $0.58 to $0.83 per share on net sales of $157 million to $166 million, compared to analysts' estimates of a $0.30 loss per share on $162.29 million in revenue. Despite the Q2 shortfall, Lovesac maintained its FY26 outlook, anticipating earnings of $0.80 to $1.36 per share on net sales between $700 million and $750 million, while analysts are projecting $1.62 EPS on $719.69 million in sales.

Analysis

Lovesac Co. (LOVE) has issued significantly weaker-than-anticipated loss guidance for its second quarter, projecting a loss per share between $0.58 and $0.83, which is substantially below the analyst consensus estimate of a $0.30 loss per share. Concurrently, the company's Q2 net sales guidance of $157 million to $166 million has a midpoint of $161.5 million, slightly trailing the consensus of $162.29 million, although the range does encompass the analyst projection. This near-term pessimism, underscored by a strongly negative sentiment score of -0.7 for LOVE, contrasts with the company's decision to maintain its full-year fiscal 2026 outlook. However, this reaffirmed FY26 guidance, targeting earnings per share of $0.80 to $1.36 on net sales between $700 million and $750 million, still lags behind current Street expectations, which call for earnings of $1.62 per share on net sales of $719.69 million. This discrepancy suggests that even the maintained long-term outlook implies performance below what analysts currently anticipate, indicating potential challenges in bridging this gap.

Key Decisions for Investors

• Investors should anticipate near-term negative pressure on Lovesac's stock due to the Q2 loss guidance being substantially wider and deeper than market expectations, signaling potential operational headwinds or increased cost pressures.
• Re-evaluate medium-term expectations for Lovesac, as the maintained FY26 earnings guidance of $0.80-$1.36 per share remains considerably below the analyst consensus of $1.62, suggesting that current street forecasts may be overly optimistic.
• Closely monitor upcoming analyst estimate revisions for both Q2 and FY26, and scrutinize future earnings calls for detailed explanations regarding the drivers of the Q2 weakness and the pathway to achieving the maintained, yet below-consensus, full-year targets.